As I mentioned earlier, according to a 2016 study published in Currents in Neuropharmacology, it may also support the gut-brain barrier, which is critical for your gut and brain health ( 7 )
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
The analysis also includes tirzepatide (Mounjaro and Zepbound), which is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist (and classified under A10BX or other blood glucose lowering drugs, excl
Pereira C.F, de Oliveira C.R
These supplements are meant to be paired with a very low-calorie (as little as 500 calories per day) diet
Potential risks include changes in growth hormones, abnormal tissue growth, or interference with Tissue Regeneration pathways